Insider Holders & Insider Ownership - REGENERON PHARMACEUTICALS INC (REGN)

List of insiders holdings for REGENERON PHARMACEUTICALS INC:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
# Insider Holder Name Report
Date Time		 Shares Owned
Directly
Indirectly		 Total
Shares Owned		 Filing
1 SCHLEIFER LEONARD S
Bd. Co-Chair, President & CEO		 2024-06-13 16:01:19 2,177,667
178,259		 2,355,926 Form 4
2 YANCOPOULOS GEORGE
Bd. Co-Chair, President & CSO		 2024-06-12 16:10:49 868,994
241,951		 1,110,945 Form 4
3 VAGELOS P ROY
Director		 2023-04-05 16:02:23 312,578
154,526		 467,104 Form 4
4 SANOFI-AVENTIS
Sanofi-Aventis Amerique du Nord S.N.C.
10% Owner		 2020-06-17 17:10:15 279,766
0		 279,766 Form 13D
5 Sanofi
10% Owner		 2020-06-17 17:10:15 279,766
0		 279,766 Form 13D
6 GOLDBERG MURRAY A
SVP Administration & Asst Secr		 2014-12-18 16:25:06 142,515
6,400		 148,915 Form 4
7 RUPP RANDALL
SVP, Manufuring Operations		 2007-04-17 14:25:18 142,137
0		 142,137 Form 4
8 ROBERTS WILLIAM
VP Reg Dev & Med Safety		 2014-02-06 16:41:18 16,644
55,634		 72,278 Form 5
9 GULER HANS PETER
VP Clinical Programs		 2004-10-12 12:02:08 67,152
0		 67,152 Form 4
10 STAHL NEIL
EVP Research and Development		 2024-12-18 16:02:59 48,829
10,454		 59,283 Form 4
11 MURPHY ANDREW J
EVP Research		 2024-12-18 16:02:34 49,074
4,326		 53,400 Form 4
12 LAROSA JOSEPH J
EVP General Counsel and Secret		 2024-12-18 16:01:51 30,075
9,371		 39,446 Form 4
13 Van Plew Daniel P
EVP & General Mgr, Industrial		 2024-12-18 16:03:11 34,792
1,100		 35,892 Form 4
14 Landry Robert E
EVP Finance CFO		 2024-02-06 16:08:17 35,480
270		 35,750 Form 4
15 Powchik Peter
SVP Clinical Development & Reg		 2016-12-19 16:15:06 30,714
4,133		 34,847 Form 4
16 Terifay Robert J
EVP Commercial		 2017-12-13 16:52:29 32,300
0		 32,300 Form 4
17 SING GEORGE L
Director		 2025-01-03 16:02:28 29,786
2,150		 31,936 Form 4
18 Dworkin Peter
VP Investor Relations & Commun		 2009-12-22 11:21:13 23,500
0		 23,500 Form 4
19 SHOOTER ERIC M
Director		 2014-02-13 19:38:09 15,000
5,085		 20,085 Form 4
20 KOLINSKI STUART
SVP General Counsel and Secret		 2010-06-07 16:14:10 16,329
3,710		 20,039 Form 4
21 Aberman Michael S
SVP Strategy Investor Relation		 2017-06-23 16:10:08 7,693
12,253		 19,946 Form 4
22 Fenimore Christopher R.
SVP Finance & CFO		 2024-12-18 16:01:20 16,265
3,462		 19,727 Form 4
23 RYAN ARTHUR F
Director		 2025-01-06 16:08:27 19,706
0		 19,706 Form 4
24 INGRAM ROBERT ALEXANDER
Director		 2015-05-27 16:02:35 14,833
0		 14,833 Form 4
25 BROWN MICHAEL S
Director		 2025-01-06 16:05:22 3,506
11,162		 14,668 Form 4
26 McCourt Marion
EVP Commercial		 2024-12-18 16:02:07 14,230
174		 14,404 Form 4
27 McCorkle Douglas S
VP Controller and Asst Treasur		 2015-12-29 19:44:10 6,866
4,129		 10,995 Form 4
28 GILMAN ALFRED G
Director		 2015-08-07 18:15:04 8,912
0		 8,912 Form 4
29 GOLDSTEIN JOSEPH L
Director		 2025-01-06 16:06:04 8,506
0		 8,506 Form 4
30 BAKER CHARLES A
Director		 2018-01-03 16:14:21 7,439
0		 7,439 Form 4
31 Pitofsky Jason
VP Controller		 2024-12-18 16:02:48 4,664
190		 4,854 Form 4
32 Tessier-Lavigne Marc
Director		 2023-01-05 16:16:35 4,363
0		 4,363 Form 4
33 POON CHRISTINE A
Director		 2025-01-06 16:07:40 4,310
0		 4,310 Form 4
34 COLES N ANTHONY
Director		 2025-01-06 16:12:14 3,517
0		 3,517 Form 4
35 Bassler Bonnie L
Director		 2025-01-06 16:04:09 3,506
0		 3,506 Form 4
36 Zoghbi Huda Y
Director		 2025-01-06 16:11:47 3,506
0		 3,506 Form 4
37 Thompson Craig B.
Director		 2025-01-06 16:13:03 2,578
0		 2,578 Form 4
38 Schenkein David P
Director		 2025-01-06 17:42:19 2,406
0		 2,406 Form 4
39 Guarini Kathryn
Director		 2025-01-06 16:06:55 2,406
0		 2,406 Form 4
40 NOVARTIS PHARMA AG
10% Owner		 2005-11-10 14:56:08 0
0		 0 Form 13G